AXL inhibition improves BRAF-targeted treatment in melanoma.
Nyakas M, Fleten KG, Haugen MH, Engedal N, Sveen C, Farstad IN, Flørenes VA, Prasmickaite L, Mælandsmo GM, Seip K.
Nyakas M, et al. Among authors: seip k.
Sci Rep. 2022 Mar 24;12(1):5076. doi: 10.1038/s41598-022-09078-z.
Sci Rep. 2022.
PMID: 35332208
Free PMC article.